# Vascarta Inc.: Form D filings

Vascarta Inc., a pharmaceuticals company in Summit, NJ, filed 4 Form D notices with the SEC between 2020 and 2022. The latest, on March 11, 2022, reports $75,000 sold of an offering with no set size to 2 investors.

Find out what Vascarta Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Vascarta%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Vascarta%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fvascarta-inc-1823616)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Vascarta%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Vascarta%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fvascarta-inc-1823616)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in New Jersey](https://specstream.ai/data/form-d/state/new-jersey): 714 rows, by operating companies, filed since November 1, 2024, $35.70, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/new-jersey
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 4 CHATHAM ROAD, SECOND FLOOR, Summit, NJ, 07901
- Phone: (973) 321-7521
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2020
- Revenue range: No Revenues
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1823616

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Mar 11, 2022 | Amendment | Indefinite | $75,000 | Indefinite | 2 | Feb 24, 2022 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1823616/000182361622000002/0001823616-22-000002-index.htm) |
| Mar 11, 2022 | New notice | Indefinite | $50,000 | Indefinite | 1 | Feb 24, 2022 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1823616/000182361622000001/0001823616-22-000001-index.htm) |
| Apr 1, 2021 | Amendment | $1,000,000 | $648,500 | $351,500 | 13 | Aug 25, 2020 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1823616/000182361621000001/0001823616-21-000001-index.htm) |
| Sep 10, 2020 | New notice | $500,000 | $90,000 | $410,000 | 2 | Aug 25, 2020 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1823616/000182361620000001/0001823616-20-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Joel Friedman, MD, PhD | Executive Officer, Director |  |
| Graeme Silbert | Executive Officer |  |
| Travis Gering | Executive Officer, Director |  |
| Richard Prince, PhD | Executive Officer, Director |  |

## Other pharmaceuticals companies in New Jersey that filed recently

- [Grace Therapeutics, Inc.](https://specstream.ai/data/form-d/company/grace-therapeutics-inc-1444192) $10 million · Aug 11, 2026

[Every Form D from the week of Mar 7, 2022](https://specstream.ai/data/form-d/week/2022-03-07) · [All recent filings in New Jersey](https://specstream.ai/data/form-d/state/new-jersey) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Vascarta Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).